Print    Close

Tidal Provides Corporate Update

Vancouver, British Columbia--(Newsfile Corp. - October 18, 2019) - Tidal Royalty Corp. (CSE: RLTY.U) (OTC: TDRYF) ("Tidal" or the "Company") is pleased to provide an update further to the executed business combination agreement with MichiCann Medical Inc. (operating as Red White & Bloom) ("MichiCann").

The transaction with MichiCann is steadily and strategically moving forward, staying true to the original overall strategy, which is to achieve critical mass within our target markets, while rapidly and aggressively expanding in the U.S. cannabis and CBD business.

We want to assure our shareholders that we are continuing to closely monitor public market conditions, drawing on our own experience in capital market strategy and seeking the advice of many seasoned capital markets veterans to identify the appropriate time to close the MichiCann amalgamation transaction.

We are also pleased to provide the following operational and production updates from MichiCann:

OPERATIONAL UPDATES

PRODUCTION UPDATES:

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/5965/48894_7cc866f0d4267899_002.jpg

Figure 1: Pictures from the Illinois Facility
(https://market-alert.com/red-white-and-bloom/ )

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/5965/48894_7cc866f0d4267899_002full.jpg

The pictures above show how quickly MichiCann has been able to convert its facility into CBD production, with roughly 2.5 million sq. ft. now growing legal, high yield CBD strains. MichiCann has been working closely with staff in Illinois for the past three months, whom have quickly adapted to a new crop, and have been able to grow outstanding strains for live resin extraction and whole flower.

We wish to thank our shareholders for their continued patience and support as we work to execute our strategy.

For further information, please contact:
Tidal Royalty Corp.
Theo van der Linde, Chief Financial Officer & Director
Phone: 604-687-2038

Cautionary Note Regarding Forward-Looking Information and Statements

Forward-Looking Information: This news release includes certain statements that may be deemed "forward-looking statements". The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "would", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents which can be found under the Company's profile on www.sedar.com

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/48894